{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T01:14:32Z","timestamp":1783300472664,"version":"3.54.6"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing-Tianjin-Hebei Basic Research Cooperation Special Project","award":["No.22JCZXJC00180"],"award-info":[{"award-number":["No.22JCZXJC00180"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04394-4","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:46:27Z","timestamp":1778557587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The efficacy and predictive value of 99mTc-rituximab for sentinel lymph node biopsy in acral melanoma patients"],"prefix":"10.1186","volume":"24","author":[{"given":"Ruifeng","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chujie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3616-1848","authenticated-orcid":false,"given":"Zhengfu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4798-5404","authenticated-orcid":false,"given":"Jiayong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"4","key":"4394_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","volume":"127","author":"DL Morton","year":"1992","unstructured":"Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4):392\u20139. https:\/\/doi.org\/10.1001\/archsurg.1992.01420040034005.","journal-title":"Arch Surg"},{"issue":"18","key":"4394_CR2","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJMct1002967","volume":"364","author":"JE Gershenwald","year":"2011","unstructured":"Gershenwald JE, Ross MI. Sentinel-lymph-node biopsy for cutaneous melanoma. N Engl J Med. 2011;364(18):1738\u201345. https:\/\/doi.org\/10.1056\/NEJMct1002967.","journal-title":"N Engl J Med"},{"issue":"6","key":"4394_CR3","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.21873\/anticanres.14325","volume":"40","author":"MT Huayllani","year":"2020","unstructured":"Huayllani MT, Restrepo DJ, Boczar D, Avila FR, Bagaria SP, Spaulding AC, et al. National comprehensive analysis of characteristics of acral lentiginous melanoma. Anticancer Res. 2020;40(6):3411\u20135. https:\/\/doi.org\/10.21873\/anticanres.14325.","journal-title":"Anticancer Res"},{"issue":"8","key":"4394_CR4","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/jso.25445","volume":"119","author":"SN Pavri","year":"2019","unstructured":"Pavri SN, Han G, Khan S, Han D. Does sentinel lymph node status have prognostic significance in patients with acral lentiginous melanoma? J Surg Oncol. 2019;119(8):1060\u20139. https:\/\/doi.org\/10.1002\/jso.25445.","journal-title":"J Surg Oncol"},{"issue":"8","key":"4394_CR5","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1097\/DSS.0000000000001785","volume":"45","author":"LF Nunes","year":"2019","unstructured":"Nunes LF, Mendes GLQ, Koifman RJ. Sentinel lymph node biopsy in patients with acral melanoma: analysis of 201 cases from the Brazilian National Cancer Institute. Dermatol Surg. 2019;45(8):1026\u201334. https:\/\/doi.org\/10.1097\/DSS.0000000000001785.","journal-title":"Dermatol Surg"},{"issue":"1","key":"4394_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/ajco.13425","volume":"17","author":"C Sohng","year":"2021","unstructured":"Sohng C, Sim HB, Kim JY, Lim Y, Han MH, Lee H, et al. Sentinel lymph node biopsy in acral melanoma: a Korean single-center experience with 107 patients (2006-2018). Asia Pac J Clin Oncol. 2021;17(1):115\u201322. https:\/\/doi.org\/10.1111\/ajco.13425.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"4","key":"4394_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/archdermatol.2008.609","volume":"145","author":"PT Bradford","year":"2009","unstructured":"Bradford PT, Goldstein AM, McMaster ML, Tucker MA. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol. 2009;145(4):427\u201334. https:\/\/doi.org\/10.1001\/archdermatol.2008.609.","journal-title":"Arch Dermatol"},{"key":"4394_CR8","doi-asserted-by":"publisher","unstructured":"Chi Z, S L, X S, L S, C C, M H, et al. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases. BMC Cancer. 2011;11:85. https:\/\/doi.org\/10.1186\/1471-2407-11-85.","DOI":"10.1186\/1471-2407-11-85"},{"issue":"1","key":"4394_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.47102\/annals-acadmedsg.V41N1p17","volume":"41","author":"HY Lee","year":"2012","unstructured":"Lee HY, Chay WY, Tang MB, Chio MT, Tan SH. Melanoma: differences between Asian and Caucasian patients. Ann Acad Med Singap. 2012;41(1):17\u201320.","journal-title":"Ann Acad Med Singap"},{"issue":"2","key":"4394_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejso.2016.06.407","volume":"43","author":"JA Moody","year":"2017","unstructured":"Moody JA, Ali RF, Carbone AC, Singh S, Hardwicke JT. Complications of sentinel lymph node biopsy for melanoma - a systematic review of the literature. Eur J Surg Oncol. 2017;43(2):270\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2016.06.407.","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"4394_CR11","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1245\/aso.2003.10.001","volume":"10","author":"WR Wrightson","year":"2003","unstructured":"Wrightson WR, Wong SL, Edwards MJ, Chao C, Reintgen DS, Ross MI, et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol. 2003;10(6):676\u201380. https:\/\/doi.org\/10.1245\/aso.2003.10.001.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4394_CR12","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/j.suronc.2010.10.002","volume":"20","author":"C B\u00e9zu","year":"2011","unstructured":"B\u00e9zu C, Coutant C, Salengro A, Dara\u00ef E, Rouzier R, Uzan S. Anaphylactic response to blue dye during sentinel lymph node biopsy. Surg Oncol. 2011;20(1):e55-59. https:\/\/doi.org\/10.1016\/j.suronc.2010.10.002.","journal-title":"Surg Oncol"},{"issue":"9","key":"4394_CR13","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.bjps.2013.03.036","volume":"66","author":"SA Clarke","year":"2013","unstructured":"Clarke SA, Molajo A, Powell BW. Incidence of adverse reactions to Patent Blue dye in melanoma sentinel node biopsy: a major UK centre experience. J Plast Reconstr Aesthet Surg. 2013;66(9):1299\u2013300. https:\/\/doi.org\/10.1016\/j.bjps.2013.03.036.","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"8","key":"4394_CR14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.ejso.2004.06.021","volume":"30","author":"N Wasserberg","year":"2004","unstructured":"Wasserberg N, Tulchinsky H, Schachter J, Feinmesser M, Gutman H. Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free. Eur J Surg Oncol. 2004;30(8):851\u20136. https:\/\/doi.org\/10.1016\/j.ejso.2004.06.021.","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"4394_CR15","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.ejso.2005.05.003","volume":"31","author":"M de Vries","year":"2005","unstructured":"de Vries M, Vonkeman WG, van Ginkel RJ, Hoekstra HJ. Morbidity after axillary sentinel lymph node biopsy in patients with cutaneous melanoma. Eur J Surg Oncol. 2005;31(7):778\u201383. https:\/\/doi.org\/10.1016\/j.ejso.2005.05.003.","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"4394_CR16","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.bjps.2018.04.020","volume":"71","author":"JM Ranson","year":"2018","unstructured":"Ranson JM, Pantelides NM, Pandit DG, Laitung J. Sentinel lymph node biopsy in melanoma: which hot nodes should be harvested and is blue dye really necessary? J Plast Reconstr Aesthet Surg. 2018;71(9):1269\u201373. https:\/\/doi.org\/10.1016\/j.bjps.2018.04.020.","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"4","key":"4394_CR17","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ejso.2015.12.007","volume":"42","author":"MG Niebling","year":"2016","unstructured":"Niebling MG, Pleijhuis RG, Bastiaannet E, Brouwers AH, van Dam GM, Hoekstra HJ. A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping. Eur J Surg Oncol. 2016;42(4):466\u201373. https:\/\/doi.org\/10.1016\/j.ejso.2015.12.007.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"4394_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/DSS.0000000000000961","volume":"43","author":"N Pham Dang","year":"2017","unstructured":"Pham Dang N, Cassier S, Mulliez A, Mansard S, D\u02bcIncan M, Barth\u00e9l\u00e9my I. Eight years\u2019 experience of sentinel lymph node biopsy in melanoma using lymphoscintigraphy and gamma probe detection after radiocolloid mapping. Dermatol Surg. 2017;43(2):287\u201392. https:\/\/doi.org\/10.1097\/DSS.0000000000000961.","journal-title":"Dermatol Surg"},{"issue":"5","key":"4394_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/CMR.0000000000000271","volume":"26","author":"IMC van der Ploeg","year":"2016","unstructured":"van der Ploeg IMC, Madu MF, van der Hage JA, Wouters MWJM, Klop WMC, van der Hiel B, et al. Blue dye can be safely omitted in most sentinel node procedures for melanoma. Melanoma Res. 2016;26(5):464\u20138. https:\/\/doi.org\/10.1097\/CMR.0000000000000271.","journal-title":"Melanoma Res"},{"issue":"suppl 1","key":"4394_CR20","first-page":"441P","volume":"47","author":"XJ Wang","year":"2006","unstructured":"Wang XJ, Lin BH, Yang Z, Ouyang T, Liu JF, Xu B, et al. 99mTc-IT-rituximab: an effective radiotracer for identifying sentinel lymph nodes in breast cancer. J Nucl Med. 2006;47(suppl 1):441P.","journal-title":"J Nucl Med"},{"issue":"2","key":"4394_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.21037\/atm-21-6890","volume":"10","author":"J Liu","year":"2022","unstructured":"Liu J, Tan Z, Xue R, Fan Z, Bai C, Li S, et al. The efficacy of 99mTc-rituximab as a tracer for sentinel lymph node biopsy in cutaneous melanoma patients. Ann Transl Med. 2022;10(2):95. https:\/\/doi.org\/10.21037\/atm-21-6890.","journal-title":"Ann Transl Med"},{"issue":"8","key":"4394_CR22","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.2967\/jnumed.115.160572","volume":"57","author":"N Li","year":"2016","unstructured":"Li N, Wang X, Lin B, Zhu H, Liu L, Xu X, et al. Clinical evaluation of 99mTc-rituximab for sentinel lymph node mapping in breast cancer patients. J Nucl Med. 2016;57(8):1214\u201320. https:\/\/doi.org\/10.2967\/jnumed.115.160572.","journal-title":"J Nucl Med"},{"issue":"2","key":"4394_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10549-017-4591-z","volume":"168","author":"J Wang","year":"2018","unstructured":"Wang J, Fan T, He Y, Chen X, Fan Z, Xie Y, et al. 99mTc-rituximab as a tracer for sentinel lymph node biopsy in breast cancer patients: a single-center analysis. Breast Cancer Res Treat. 2018;168(2):365\u201370. https:\/\/doi.org\/10.1007\/s10549-017-4591-z.","journal-title":"Breast Cancer Res Treat"},{"issue":"29","key":"4394_CR24","doi-asserted-by":"publisher","first-page":"45671","DOI":"10.18632\/oncotarget.10140","volume":"7","author":"J Chen","year":"2016","unstructured":"Chen J, Xu Y, Zhou Y, Wang Y, Zhu H, Shi Y. Prognostic role of sentinel lymph node biopsy for patients with cutaneous melanoma: a retrospective study of surveillance, epidemiology, and end-result population-based data. Oncotarget. 2016;7(29):45671\u20137. https:\/\/doi.org\/10.18632\/oncotarget.10140.","journal-title":"Oncotarget"},{"issue":"2","key":"4394_CR25","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1245\/s10434-020-08706-0","volume":"28","author":"D Han","year":"2021","unstructured":"Han D, Han G, Duque MT, Morrison S, Leong SP, Kashani-Sabet M, et al. Sentinel lymph node biopsy is prognostic in thickest melanoma cases and should be performed for thick melanomas. Ann Surg Oncol. 2021;28(2):1007\u201316. https:\/\/doi.org\/10.1245\/s10434-020-08706-0.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4394_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4103\/0970-0358.113717","volume":"46","author":"J Lima S\u00e1nchez","year":"2013","unstructured":"Lima S\u00e1nchez J, S\u00e1nchez Medina M, Garc\u00eda Duque O, Fi\u00faza P\u00e9rez M, Carreteri Hern\u00e1ndez G, Fern\u00e1ndez Pal\u00e1cios J. Sentinel lymph node biopsy for cutaneous melanoma: a 6 years study. Indian J Plast Surg. 2013;46(1):92\u20137. https:\/\/doi.org\/10.4103\/0970-0358.113717.","journal-title":"Indian J Plast Surg"},{"issue":"9","key":"4394_CR27","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s12094-020-02306-w","volume":"22","author":"JA Avil\u00e9s-Izquierdo","year":"2020","unstructured":"Avil\u00e9s-Izquierdo JA, Nieto-Benito LM, L\u00e1zaro-Ochaita P, Escat-Cort\u00e9s JL, Marquez-Rodas I, Mercader-Cidoncha E. Prognostic significance of sentinel node biopsy status in cutaneous melanoma: a 21-years prospective study from a single institution. Clin Transl Oncol. 2020;22(9):1611\u20138. https:\/\/doi.org\/10.1007\/s12094-020-02306-w.","journal-title":"Clin Transl Oncol"},{"issue":"7","key":"4394_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/BF02574479","volume":"9","author":"CR Ferrone","year":"2002","unstructured":"Ferrone CR, Panageas KS, Busam K, Brady MS, Coit DG. Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status. Ann Surg Oncol. 2002;9(7):637\u201345. https:\/\/doi.org\/10.1007\/BF02574479.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"4394_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000362902","volume":"229","author":"C Munsch","year":"2014","unstructured":"Munsch C, Lauwers-Cances V, Lamant L, Gentil C, Rochaix P, Garrido I, et al. Breslow thickness, Clark index and ulceration are associated with sentinel lymph node metastasis in melanoma patients: a cohort analysis of 612 patients. Dermatology. 2014;229(3):183\u20139. https:\/\/doi.org\/10.1159\/000362902.","journal-title":"Dermatology"},{"issue":"10","key":"4394_CR30","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/cncr.29239","volume":"121","author":"M Yamamoto","year":"2015","unstructured":"Yamamoto M, Fisher KJ, Wong JY, Koscso JM, Konstantinovic MA, Govsyeyev N, et al. Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma. Cancer. 2015;121(10):1628\u201336. https:\/\/doi.org\/10.1002\/cncr.29239.","journal-title":"Cancer"},{"issue":"12","key":"4394_CR31","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1245\/s10434-006-9066-0","volume":"13","author":"ZI Nowecki","year":"2006","unstructured":"Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Ann Surg Oncol. 2006;13(12):1655\u201363. https:\/\/doi.org\/10.1245\/s10434-006-9066-0.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"4394_CR32","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1245\/s10434-015-4912-6","volume":"23","author":"DY Lee","year":"2016","unstructured":"Lee DY, Huynh KT, Teng A, Lau BJ, Vitug S, Lee JH, et al. Predictors and survival impact of false-negative sentinel nodes in melanoma. Ann Surg Oncol. 2016;23(3):1012\u20138. https:\/\/doi.org\/10.1245\/s10434-015-4912-6.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"4394_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jfma.2013.06.018","volume":"114","author":"CE Wu","year":"2015","unstructured":"Wu CE, Hsieh CH, Chang CJ, Yeh JT, Kuo TT, Yang CH, et al. Prognostic factors for Taiwanese patients with cutaneous melanoma undergoing sentinel lymph node biopsy. J Formos Med Assoc. 2015;114(5):415\u201321. https:\/\/doi.org\/10.1016\/j.jfma.2013.06.018.","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"4394_CR34","first-page":"105","volume":"58","author":"G Manca","year":"2014","unstructured":"Manca G, Romanini A, Rubello D, Mazzarri S, Boni G, Chiacchio S, et al. A critical reappraisal of false negative sentinel lymph node biopsy in melanoma. Q J Nucl Med Mol Imaging. 2014;58(2):105\u201313.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"7","key":"4394_CR35","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.1097\/RLU.0000000000000366","volume":"39","author":"G Manca","year":"2014","unstructured":"Manca G, Rubello D, Romanini A, Boni G, Chiacchio S, Tredici M, et al. Sentinel lymph node mapping in melanoma: the issue of false-negative findings. Clin Nucl Med. 2014;39(7):e346-354. https:\/\/doi.org\/10.1097\/RLU.0000000000000366.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"4394_CR36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ejso.2016.08.007","volume":"43","author":"MF Madu","year":"2017","unstructured":"Madu MF, Wouters MWJM, van Akkooi ACJ. Sentinel node biopsy in melanoma: current controversies addressed. Eur J Surg Oncol. 2017;43(3):517\u201333. https:\/\/doi.org\/10.1016\/j.ejso.2016.08.007.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"4394_CR37","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1245\/s10434-009-0858-x","volume":"17","author":"CR Scoggins","year":"2010","unstructured":"Scoggins CR, Martin RCG, Ross MI, Edwards MJ, Reintgen DS, Urist MM, et al. Factors associated with false-negative sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol. 2010;17(3):709\u201317. https:\/\/doi.org\/10.1245\/s10434-009-0858-x.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"4394_CR38","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1245\/s10434-007-9433-5","volume":"14","author":"C Carac\u00f2","year":"2007","unstructured":"Carac\u00f2 C, Marone U, Celentano E, Botti G, Mozzillo N. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma. Ann Surg Oncol. 2007;14(9):2662\u20137. https:\/\/doi.org\/10.1245\/s10434-007-9433-5.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"4394_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2217\/mmt.15.19","volume":"2","author":"M Hodges","year":"2015","unstructured":"Hodges M, Jones E, Jones T, Pearlman N, Gajdos C, Kounalakis N, et al. Analysis of melanoma recurrence following a negative sentinel lymph node biopsy. Melanoma Manag. 2015;2(3):285\u201394. https:\/\/doi.org\/10.2217\/mmt.15.19.","journal-title":"Melanoma Manag"},{"issue":"10","key":"4394_CR40","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/j.1524-4725.2010.01676.x","volume":"36","author":"V Panasiti","year":"2010","unstructured":"Panasiti V, Devirgiliis V, Curzio M, Roberti V, Gobbi S, Rossi M, et al. Predictive factors for false negative sentinel lymph node in melanoma patients. Dermatol Surg. 2010;36(10):1521\u20138. https:\/\/doi.org\/10.1111\/j.1524-4725.2010.01676.x.","journal-title":"Dermatol Surg"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04394-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04394-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04394-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:22:03Z","timestamp":1783297323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04394-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4394"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04394-4","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Peking University Cancer Hospital and Institute approved this study. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. All the patients provided written informed consent before SLNB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"278"}}